期刊文献+

血清超敏C-反应蛋白与动脉粥样硬化血栓形成性脑卒中的相关性研究 被引量:5

Correlation between High Sensitivity C-reactive Protein and Atherothrombosis Stroke
下载PDF
导出
摘要 目的:探讨血清超敏C-反应蛋白(hsCRP)水平对动脉粥样硬化血栓形成性脑卒中发生风险的预测价值。方法:采用病例-对照研究,按照TOAST分型标准,纳入动脉粥样硬化血栓形成性脑卒中患者114例为病例组,同时随机抽取门诊体检人群中无心、脑及周围动脉粥样硬化病史者130例为对照组;记录动脉粥样硬化危险因素及影响hsCRP的潜在危险因素;酶联免疫吸附法测定血清hsCRP水平,比较两组间基线hsCRP水平,并将hsCRP水平进行分层(<3mg/mL,3~10mg/mL,>10mg/mL),多因素Logistic回归模型分析不同hsCRP水平患者发生动脉粥样硬化血栓形成性脑卒中的风险。结果:病例组血清hsCRP水平高于对照组(P=0.001),校正相关危险因素后,血清hsCRP水平仍高于对照组(P=0.021);以hsCRP水平以<3mg/mL为基准,未校正任何危险因素,不同水平的hsCRP预测发生动脉粥样硬化血栓形成性脑卒中的OR值依次为1.000、2.429、5.634(P<0.05),校正相关危险因素后,OR值依次为1.000、2.005、4.277(P<0.05)。结论:hsCRP水平越高,动脉粥样硬化血栓形成性脑卒中发生风险越高。 Objective: To explore the correlation between high sensitivity C-reactive protein (hsCRP) and atherothrombosis strokes. Methods: One hundred and forty-four patients with atherothrombosis strokes and 130 patients without history of strokes and relevant vascular disea- ses (controls) were enrolled for the study respectively. All demographic parameters and associat- ed risk factors of characteristic in questionnaire are collected. The serum hsCRP level was assessed by enzyme-linked immunosorbent assay. According to hsCRP levels of below3, 3-10, and above 10 mg/L, we performed logistic regression and stratification analysis to evaluate the correlation between hs-CRP at different stages with atherothrombosis strokes. Results: The hsCRP level of the patients group was higher than that in the control group (P=0. 001). After adjustment for related risk factors,hsCRP level in the patients was still higher than that in the control group (P=0. 021). As compared with the lowest quartile of hsCRP level, OR in turn was 1. 000, 2. 429, and 5. 634 respectively (P〈0.05). After correcting related risk factors, OR in turn was 1. 000, 2. 005, and 4. 277 respectively (P〈0.05). Conclusion.. A higher hsCRP level indicates a higher risk of atherothrombosis strokes.
出处 《神经损伤与功能重建》 2012年第4期268-271,共4页 Neural Injury and Functional Reconstruction
关键词 超敏C-反应蛋白 缺血性脑卒中 动脉粥样硬化血栓形成 风险评价 high sensitivity C-reactive protein ischemic stroke atherothrombosis stroke
  • 相关文献

参考文献13

  • 1Hansson GK. Inflammation, atherosclero- sis, and coronary artery disease[J]. N Engl J Med,2005,352.1685- 1695.
  • 2Venugopal SK, Devaraj S, Yuhanna I, et al. Demonstration that C-reactive protein de- creases eNOS expression and bioactivity in human aortic endothelial cells [J]. Circula- tion, 2002,106 :1439-1441.
  • 3McColl BW, Allan SM, Rothwell NJ. Sys temie infection, inflammation and acute is chemic stroke[J]. Neuroscience,2009,158: 1049-1061.
  • 4Balciunas M, Bagdonaite L, Samalavicius R, et al. Pre-operative high sensitive C-reactive protein predicts cardiovas- cular events after coronary artery bypass grafting surgery: aprospective observational study [J]. Ann Card Anaesth,2009,12 : 127- 132.
  • 5dker PM, Silvertown JD. Inflammation, -reactive protein, and atherothrombosis [J]. J Periodontol, 2008,79: 1544- 1551.
  • 6den Hertog HM, van Rossum JA, van der Worp HB, et al. C reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death [J]. J Neurol,2009,256:2003-2008.
  • 7Pepys MB, Hirschfield GM. C-reactive pro- tein: a critical update [J]. J Clin Invest, 2003,111:1805- 1812.
  • 8Camerlingo M, Valente L, Tognozzi M, et al. C-reactive protein levels in the first three hours after acute cerebral infarction[J]. Int J Neurosci, 2011, 121:65-68.
  • 9Eikelboom JW, Hankey GJ, Baker RI, et al. C-reactive protein in ischemic stroke and its etiologic subtypes[J]. J Stroke Cerebro- vasc Dis,2003,12 : 74-81.
  • 10Rost NS, Wolf PA, Kase CS, et al. Plasma concent ration of Creactive protein and risk of ischemic stroke and transient ischemic at- tack: the Framingham study[J]. Stroke, 2001,32.2575-2579.

二级参考文献48

  • 1高晶,郭玉璞,赵庆杰,任海涛,赵燕环.颅内动脉粥样硬化的分布及炎性因素探讨[J].中华神经科杂志,2006,39(7):459-462. 被引量:20
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33004
  • 3丁则昱,李晓光,崔丽英,张承训,鄢盛恺,朱以诚,陈琳.急性期高敏感C反应蛋白对脑梗死预后的评估[J].中华神经科杂志,2007,40(1):11-14. 被引量:70
  • 4Thompson SG K J, Pyke SDM, Haverkate F, et al. The European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pcctoris. N Engl J Med, 1995, 332: 635-641.
  • 5Haverkate F, Thompson SG, Pyke SD, et al. Production of Creactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet, 1997, 349 : 462 -466.
  • 6Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med, 2005, 352: 1685-1695.
  • 7Ridker PM, Cushman M, Stampfer M J, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997, 336: 973-979.
  • 8Mega JL, Morrow DA, Cannon CP, et al. Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy. J Thromb Thrombolysis, 2006, 22: 71-76.
  • 9Ridker PM, Cannon CP, Morrow D, et al. The pravastatin or atorvastatin evaluation and infection therapy thrombolysis in myocardial infarction 22 ( PROVE IT-TIMI 22 ) investigators. Creactive protein levels and outcomes after statin therapy. N Engl J Med, 2005, 352: 20-28.
  • 10Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke, 2001,32: 917- 924.

共引文献92

同被引文献22

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部